We had the pleasure to meet with David Lawrence (London School of Hygiene and Tropical Medicine, London, UK) to discuss the phase 3 AMBITION trial results investigating liposomal amphotericin for treatment of HIV-associated Cryptococcal Meningitis.
The abstract entitled: ‘Single high-dose liposomal amphotericin based regimen for treatment of HIV-associated Cryptococcal Meningitis: results of the phase-3 Ambition-cm Randomised Trial’ was presented at IAS 2021 – the 11th International AIDS Society Conference on HIV Science (Virtual).
Questions:
- What were the aims of the AMBITION study?
- Could you tell us a little about the study design, eligibility criteria and outcome measures?
- How well were the primary and secondary outcome measures achieved?
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Katey Gabrysch.
Filmed in coverage of IAS 2021 Virtual.
